| 000 | 01336 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512020542.0 | ||
| 264 | 0 | _c19891114 | |
| 008 | 198911s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1989.tb05426.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavis, J R | |
| 245 | 0 | 0 |
_aComparison of different dose regimes of aminohydroxypropylidene-1,1-bisphosphonate (APD) in hypercalcaemia of malignancy. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cSep 1989 |
||
| 300 |
_a269-74 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCalcium _xblood |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercalcemia _xdrug therapy |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 | _aPamidronate |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aHeath, D A | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 28 _gno. 3 _gp. 269-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1989.tb05426.x _zAvailable from publisher's website |
| 999 |
_c2795786 _d2795786 |
||